Trial · NCT03189719
Adverse events630
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 630
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Pembrolizumab + SOC | 185 | 370 | 288 |
| other | Anaemia | Blood and lymphatic system disorders | Placebo + SOC | 199 | 370 | 295 |
| other | Leukopenia | Blood and lymphatic system disorders | Pembrolizumab + SOC | 25 | 370 | 56 |
| other | Leukopenia | Blood and lymphatic system disorders | Placebo + SOC | 29 | 370 | 72 |
| other | Neutropenia | Blood and lymphatic system disorders | Pembrolizumab + SOC | 95 | 370 | 190 |
| other | Neutropenia | Blood and lymphatic system disorders | Placebo + SOC | 90 | 370 | 179 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Pembrolizumab + SOC | 28 | 370 | 54 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Placebo + SOC | 37 | 370 | 57 |
| other | Tinnitus | Ear and labyrinth disorders | Pembrolizumab + SOC | 36 | 370 | 38 |
| other | Tinnitus | Ear and labyrinth disorders | Placebo + SOC | 27 | 370 | 30 |
| other | Hyperthyroidism | Endocrine disorders | Pembrolizumab + SOC | 19 | 370 | 19 |
| other | Hyperthyroidism | Endocrine disorders | Placebo + SOC | 3 | 370 | 4 |
| other | Hypothyroidism | Endocrine disorders | Pembrolizumab + SOC | 40 | 370 | 46 |
| other | Hypothyroidism | Endocrine disorders | Placebo + SOC | 24 | 370 | 27 |
| other | Abdominal pain | Gastrointestinal disorders | Pembrolizumab + SOC | 28 | 370 | 33 |
| other | Abdominal pain | Gastrointestinal disorders | Placebo + SOC | 18 | 370 | 21 |
| other | Abdominal pain upper | Gastrointestinal disorders | Pembrolizumab + SOC | 20 | 370 | 21 |
| other | Abdominal pain upper | Gastrointestinal disorders | Placebo + SOC | 27 | 370 | 41 |
| other | Constipation | Gastrointestinal disorders | Pembrolizumab + SOC | 147 | 370 | 238 |
| other | Constipation | Gastrointestinal disorders | Placebo + SOC | 149 | 370 | 210 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03189719/events